Quoting Oncology Brothers on X/Twitter:
“Yet another busy year for FDA Oncology. ≥ 40 new approvals/indications in 2023 for Heme-Onc.
Our end-of-year wrap-up tradition. Indications and study findings for the 5 approved drugs in Lung Cancer:
”
Source: Oncology Brothers/X